These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 596808)

  • 1. Significance of increased fibrin/fibrinogen degradation products and presence of fibrin monomers in pregnant women.
    Svanberg L; Eydal A; Astedt B
    Ann Chir Gynaecol Suppl; 1977; 66(5):247-50. PubMed ID: 596808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fibrin degradation products in pregnant women with nephropathies].
    Tsitsiashvili ESh
    Sov Med; 1982; (2):113-4. PubMed ID: 7063962
    [No Abstract]   [Full Text] [Related]  

  • 3. [Determination of fibrinogen derivatives in obstetrical practice].
    Makatsariia AD; Mel'nikov AP; Smolianitskiĭ AIa
    Sov Med; 1979 Jun; (6):13-7. PubMed ID: 472876
    [No Abstract]   [Full Text] [Related]  

  • 4. [Relations between products of fibrin degradation and arterial blood pressure in pregnancy complicated by nephropathy].
    Tsitsiashvili ESh
    Lab Delo; 1982; (4):230-2. PubMed ID: 6177910
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fibrin-fibrinogen degradation products and pregnancy-specific beta 1-glycoprotein (SP 1) in normal and pathological pregnancies].
    Geyer H; Nothnagel D
    Geburtshilfe Frauenheilkd; 1984 Dec; 44(12):787-91. PubMed ID: 6335446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in fibrinogen, fibrin-fibrinogen degradation products and fibrinolytic activity during pregnancy, labor and the puerperium in pregnant women with chronic hypertension].
    Kendić S; Mujezinović O; Muratović H
    Med Arh; 2000; 54(1):29-31. PubMed ID: 10872273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot].
    Okumura N; Kagiya H; Kumagai T; Kameko M; Tozuka M; Saito H; Katsuyama T; Kanai M
    Rinsho Byori; 1990 Feb; 38(2):201-7. PubMed ID: 2329722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolytic response to venous occlusion and fibrin fragment D-dimer levels in normal and complicated pregnancy.
    Ballegeer V; Mombaerts P; Declerck PJ; Spitz B; Van Assche FA; Collen D
    Thromb Haemost; 1987 Dec; 58(4):1030-2. PubMed ID: 3445223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble fibrin in plasma as a sign of activated coagulation in patients with pregnancy complications.
    Ostlund E; Bremme K; Wiman B
    Acta Obstet Gynecol Scand; 1998 Feb; 77(2):165-9. PubMed ID: 9512320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monoclonal antibodies against fibrinogen and fibrin and against their proteolytic degradation products].
    Dyr JE; Cajthamlová H; Suttnar J
    Cas Lek Cesk; 1990 Oct; 129(43):1349-51. PubMed ID: 2249231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal serum FDP and circulating fetal red cells throughout pregnancy. A longitudinal study.
    Hoq MS; Pepper J; Prescott RJ; Robertson J; Cash JD
    Thromb Diath Haemorrh; 1975 Dec; 34(3):727-33. PubMed ID: 1209542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fibrin fibrinogen degradation products in the urine and blood in patients with diabetes mellitus and renal complications].
    Astrug A; Shipkova P
    Vutr Boles; 1982; 21(5):81-8. PubMed ID: 7164412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL; Francis CW; Knutson DW; Marder VJ
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unreliability of current serum fibrin degradation product (FDP) assays.
    Gaffney PJ; Perry MJ
    Thromb Haemost; 1985 Jun; 53(3):301-2. PubMed ID: 3901388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against fibrinogen in pregnant women, in post delivery women and in the newborns.
    Kondera-Anasz Z
    Thromb Haemost; 1998 May; 79(5):963-8. PubMed ID: 9609230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen-fibrin degradation products.
    Kwaan HC
    Ann Clin Lab Sci; 1980; 10(3):234-7. PubMed ID: 7396389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [FDP in normal and pathologic pregnancy].
    Molinelli G; Carozzi S; Lamperi S
    Boll Soc Ital Biol Sper; 1976 Oct; 52(19):1583-8. PubMed ID: 1024569
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence and clinical significance of elevated fibrin(ogen) degradation product and/or D-dimer levels in liver cirrhosis patients.
    Cioni G; Cristani A; Mussini C; Grandi S; Pentore R; Zeneroli ML; Tizzanini W; Zagni G; Ventura E
    Ital J Gastroenterol; 1990 Apr; 22(2):70-4. PubMed ID: 2131934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A trial of setting of the reference intervals of thrombin antithrombin III complex and fibrin.fibrinogen degradation products in pregnant women].
    Shizuka R; Amagai H; Kojima J; Imaizumi S; Fukumura Y; Kobayashi I; Takagi T; Ibuki Y
    Rinsho Byori; 1994 Nov; 42(11):1194-8. PubMed ID: 7844893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood coagulation abnormalities associated with envenoming by Trimeresurus albolabris in Hong Kong.
    Chan JC; Kwok MM; Cockram CS; Prematilleke MN; Tomlinson B; Critchley JA
    Singapore Med J; 1993 Apr; 34(2):145-7. PubMed ID: 8266156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.